Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 489,711 | 520,758 | 0 | 0 | N/A |
| TOTAL | $502,533 | $521,514 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 155 | 130 | N/A | N/A | N/A |
| Other Non-Current Assets | 7,308 | 2,529 | 0 | 0 | 0 |
| TOTAL | $7,463 | $2,659 | $N/A | $N/A | $N/A |
| Total Assets | $509,996 | $524,173 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,508 | 1,962 | 0 | 0 | 0 |
| Accrued Expenses | 12,875 | 12,211 | 0 | 0 | N/A |
| TOTAL | $17,990 | $14,481 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 131 | 137 | 0 | 0 | 0 |
| TOTAL | $131 | $137 | $N/A | $N/A | $N/A |
| Total Liabilities | $18,121 | $14,618 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,523 | 54,416 | N/A | N/A | N/A |
| Common Shares | 7 | 7 | 0 | 0 | N/A |
| Retained earnings | -221,016 | -200,059 | 0 | 0 | N/A |
| TOTAL | $491,875 | $509,555 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $509,996 | $524,173 | $0 | $0 | $0 |